First-ever Pervasive Neurotechnology Report finds 10,000+ Patent Filings Transforming Medicine, Entertainment and Business

– Nielsen, Advanced Neu­ro­mod­u­la­tion Sys­tems, Medtron­ic, Microsoft and Brain­lab emerge as lead­ing IP holders

.

San Fran­cis­co, CA– (May 6, 2015) – Sharp­Brains, the lead­ing mar­ket research firm track­ing applied neu­ro­science, unveiled today–at the 2015 Neu­roGam­ing Summit–a new 206-page report that, for the first time, ana­lyzes the major intel­lec­tu­al prop­er­ty trends in the Per­va­sive Neu­rotech­nol­o­gy indus­try: non-inva­sive, poten­tial­ly ubiq­ui­tous neu­rotech­nolo­gies, com­mer­cial­ly viable out­side major med­ical insti­tu­tions or research facilities.

“Through this report’s wide and deep analy­sis, Sharp­Brains has made anoth­er key con­tri­bu­tion to our under­stand­ing of the tools and tech­nolo­gies that are at the fore­front of the glob­al neu­rotech­nol­o­gy indus­try, and at the fore­front of tech­nol­o­gy over­all,” high­lights Zack Lynch, Exec­u­tive Direc­tor and Founder of the Neu­rotech­nol­o­gy Indus­try Orga­ni­za­tion.

Over the past two years a Sharp­Brains team, cross­ing the silos of sci­ence, intel­lec­tu­al prop­er­ty, tech­nol­o­gy and busi­ness, first iden­ti­fied and then ana­lyzed more than 10,000 patent fil­ings to cap­ture the core themes of a game-chang­ing indus­try: Per­va­sive Neu­rotech­nol­o­gy. Tech­nol­o­gy, root­ed in neu­ro­science, non-inva­sive and poten­tial­ly ubiq­ui­tous, designed to mon­i­tor brain activ­i­ty, to change it and to inter­face the brain with a wide range of med­ical, indus­tri­al, con­sumer and com­pu­ta­tion­al appli­ca­tions, build­ing on tech­nolo­gies such as elec­troen­cephalog­ra­phy (EEG and qEEG), neu­ro-mon­i­tor­ing, neu­rocog­ni­tive train­ing, tran­scra­nial stim­u­la­tion (TMS and tCDS), vir­tu­al real­i­ty and more.

“Neu­rotech­nol­o­gy, our analy­sis reveals, is going to become per­va­sive with­in and beyond the med­ical domain,” said Alvaro Fer­nan­dez, the report’s Edi­tor-In-Chief. “The num­ber of patent fil­ings in the space is grow­ing at unprece­dent­ed rates, and we are proud to offer this unique win­dow into the future for exec­u­tives, entre­pre­neurs, researchers, and devel­op­ers at the fore­front of innovation.”

An info­graph­ic, avail­able HERE, sum­ma­rizes key find­ings of the report, titled Per­va­sive Neu­rotech­nol­o­gy: A Ground­break­ing Analy­sis of 10,000+ Patent Fil­ings Trans­form­ing Med­i­cine, Health, Enter­tain­ment and Busi­ness.

“All too often, neu­ro­science has been siloed in acad­e­mia and med­ical cen­ters, large­ly absent from main­stream inno­va­tion process­es. The oppor­tu­ni­ty with #Per­va­siveNeu­rotech is to gain a seat at the big table, to con­tribute to the future of the dig­i­tal rev­o­lu­tion and human progress,” adds Olivi­er Oul­li­er, PhD, Pro­fes­sor of Behav­ioral and Brain Sci­ences at Aix-Mar­seille Uni­ver­si­ty.

Lead­ing 30 Hold­ers of Per­va­sive Neu­rotech­nol­o­gy Intel­lec­tu­al Property:

To iden­ti­fy key patents and lead­ing IP hold­ers, the Sharp­Brains team devel­oped a pro­pri­etary IP Strength Index, com­bin­ing quan­ti­ta­tive and qual­i­ta­tive cri­te­ria. As a result of which, these are the Lead­ing 30 IP Hold­ers in the industry:

1. Nielsen (NYSE:NLSN)
2. Advanced Neu­ro­mod­u­la­tion Systems
3. Medtron­ic (NYSE:MDT)
4. Microsoft (NASDAQ:MSFT)
5. Brain­lab
6. Posit Sci­ence
7. Body­Media (Jaw­bone)
8. Neu­ro­net­ics
9. Neu­roPace
10. Accen­ture (NYSE:ACN)
11. Gen­er­al Elec­tric (NYSE:GE)
12. Neu­roSky
13. Lumos Labs
14. IBM (NYSE:IBM)
15. Sci­en­tif­ic Learn­ing (OTCMKTS:SCIL)
16. McLean Hos­pi­tal Corp
17. Health Hero Net­work (Bosch)
18. Philips (NYSE:PHG)
19. New York University
20. Sed­line (Masi­mo NASDAQ:MASI)
21. CNS Response (OTCMKTS:CNSO)
22. Com­pumedics (ASX:CMP)
23. Stan­ford University
24. Cog­nifit
25. Inven­tion Sci­ence Fund
26. Brain.com / Braintainment
27. Advanced Brain Monitoring
28. Natus Med­ical (NASDAQ:BABY)
29. Life­watch Tech (SWX:LIFE)
30. Neo­sync

To learn more about the report, vis­it https://sharpbrains.com/pervasive-neurotechnology/

PRESS CONTACT:
Nikhil Sriraman
(415) 318‑3467
nsriraman@sharpbrains.com